275
Views
25
CrossRef citations to date
0
Altmetric
Letters to the Editor

Dasatinib-induced acute hepatitis

, , , , , & show all
Pages 1630-1632 | Received 14 Apr 2008, Accepted 15 Apr 2008, Published online: 01 Jul 2009

References

  • Keam S J. Dasatinib in chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. BioDrugs 2008; 22: 59–69
  • Danan G, Benichou C. Causality assessment of adverse reactions to drugs. A novel method based on the conclusions of international consensus meetings: application to drug-induced liver injuries. J Clin Epidemiol 1993; 46: 1323–1330
  • Ohyashiki K, Kuriyama Y, Nakajima A, Tauchi T, Ito Y, Miyazawa K, et al. Imatinib mesylate-induced hepatotoxicity in chronic myeloid leukemia demonstrated focal necrosis resembling acute viral hepatitis. Leukemia 2002; 16: 2160–2161
  • Cross T J, Bagot C, Portmann B, Wendon J, Gillett D. Imatinib mesylate as a cause of acute liver failure. Am J Hematol 2006; 81: 189–192
  • Lin N U, Sarantopoulos S, Stone J R, Galinsky I, Stone R M, Deangelo D J, et al. Fatal hepatic necrosis following imatinib mesylate therapy. Blood 2003; 102: 3455–3456
  • Ridruejo E, Cacchione R, Villamil A G, Marciano S, Gadano A C, Mando O G. Imatinib-induced fatal acute liver failure. World J Gastroenterol 2007; 13: 6608–6111
  • Al Sobhi E, Zahrani Z, Zevallos E, Zuraiki A. Imatinib-induced immune hepatitis: case report and literature review. Hematology 2007; 12: 49–53
  • Dhalluin-Venier V, Besson C, Dimet S, Thirot-Bibault A, Tchernia G, Buffet C. Imatinib mesylate-induced acute hepatitis with autoimmune features. Eur J Gastroenterol Hepatol 2006; 18: 1235–1237
  • Pariente A, Etcharry F, Cales V, Laborde Y, Ferrari S, Biour M. Imatinib mesylate-induced acute hepatitis in a patient treated for gastrointestinal stromal tumour. Eur J Gastroenterol Hepatol 2006; 18: 785–787
  • Ikuta K, Torimoto Y, Jimbo J, Inamura J, Shindo M, Sato K, et al. Severe hepatic injury caused by imatinib mesylate administered for the treatment of chronic myeloid leukemia and the efficacy of prednisolone for its management. Int J Hematol 2005; 82: 343–346
  • James C, Trouette H, Marit G, Cony-Makhoul P, Mahon F X. Histological features of acute hepatitis after imatinib mesylate treatment. Leukemia 2003; 17: 978–979
  • Rocca P, El Jastimi S, Troncy J, Scoazec J Y, Boucher A, Vial T, et al. Acute cytolytic hepatitis induced by imatinib mesylate [in French]. Gastroenterol Clin Biol 2004; 28: 918–919

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.